Who
Bradford K. Amman
Principal Accounting Officer
Company insider
Files Form 4 as: Principal Accounting Officer, Vivos Therapeutics; CFO, Treasurer, Secretary, Lifevantage.
In numbers
- Trades disclosed
- 20
- Buys
- 3
- Sells
- 0
- Bought
- $23K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 21 Feb 2008
- Last trade
- 31 Jul 2026
- Last filed
- 26 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Jul 2026filed 26 Aug 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Code A | $103K250,000 at $0.41 | filing |
| 31 Jul 2026filed 26 Aug 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $62K150,000 at $0.41 | filing |
| 31 Jul 2026filed 26 Aug 2026 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $62K150,000 at $0.41 | filing |
| 31 Jul 2026filed 26 Aug 2026 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Code A | $103K250,000 at $0.41 | filing |
| 26 Nov 2024filed 27 Nov 2024 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $395K149,533 at $2.64 | filing |
| 20 Jun 2024filed 28 Jun 2024 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $36K15,000 at $2.38 | filing |
| 23 Dec 2022filed 28 Dec 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $96K200,000 at $0.48 | filing |
| 25 Feb 2022filed 28 Feb 2022 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $164K50,000 at $3.27 | filing |
| 31 Aug 2021filed 2 Sep 2021 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $263K50,000 at $5.26 | filing |
| 25 May 2021filed 25 May 2021 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $5,2901,000 at $5.29 | filing |
| 12 Mar 2021filed 2 Sep 2021 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $750K100,000 at $7.50 | filing |
| 12 Mar 2021filed 17 Mar 2021 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $750K100,000 at $7.50 | filing |
| 24 Dec 2020filed 28 Dec 2020 | VVOS Vivos TherapeuticsMedical Devices | SEC FORM 4 Bought | $7,3801,000 at $7.38 | filing |
| 18 Nov 2019filed 2 Sep 2021 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $125K16,667 at $7.50 | filing |
| 22 Oct 2018filed 2 Sep 2021 | VVOS Vivos Therapeuticsoption or derivative · Medical Devices | SEC FORM 4 Code A | $625K83,334 at $7.50 | filing |
| 7 Apr 2009filed 9 Apr 2009 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code P | $25K50,000 at $0.50 | filing |
| 7 Apr 2009filed 9 Apr 2009 | LFVN LifevantageBiotechnology | SEC FORM 4 Bought | $10K50,000 at $0.20 | filing |
| 27 Mar 2009filed 9 Apr 2009 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code A | $84K120,000 at $0.70 | filing |
| 21 Feb 2008filed 7 Mar 2008 | LFVN Lifevantageoption or derivative · Biotechnology | SEC FORM 4 Code A | $42K120,000 at $0.35 | filing |
| 21 Feb 2008filed 7 Mar 2008 | LFVN LifevantageBiotechnology | SEC FORM 4 Code A | $5,00714,307 at $0.35 | filing |
News
Vivos Therapeutics Strikes $12M Stock Deal For SOD Sciences Stake And Test RightsVVOS · rttnews.com · 15 Oct 2026LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)LFVN · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name Bradford K. Amman; 2 articles from the last 14 days about the 2 companies they traded most, at most three about any one of them.